"Sphingosine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed)
| Descriptor ID |
D013110
|
| MeSH Number(s) |
D02.033.100.700 D02.033.455.843 D02.092.063.700
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sphingosine".
Below are MeSH descriptors whose meaning is more specific than "Sphingosine".
This graph shows the total number of publications written about "Sphingosine" by people in this website by year, and whether "Sphingosine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 7 | 1 | 8 |
| 2018 | 4 | 3 | 7 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Sphingosine" by people in Profiles.
-
Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients. Sci Rep. 2021 07 09; 11(1):14232.
-
Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19. Int J Infect Dis. 2021 Jun; 107:232-233.
-
Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis. Drugs. 2021 Jun; 81(9):985-1002.
-
The Anti-Infectious Role of Sphingosine in Microbial Diseases. Cells. 2021 05 04; 10(5).
-
The riddle of the Sphinx: why sphingosine-1-phosphate may help define molecular mechanisms underlying risk stratification for serious COVID-19 infections. EMBO Mol Med. 2021 01 11; 13(1):e13533.
-
Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19. EMBO Mol Med. 2021 01 11; 13(1):e13424.
-
Rationale for the use of sphingosine analogues in COVID-19 patients. Clin Med (Lond). 2021 Jan; 21(1):e84-e87.
-
IL-4/IL-13 remodeling pathway of COVID-19 lung injury. Sci Rep. 2020 10 29; 10(1):18689.
-
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int J Mol Sci. 2020 Sep 29; 21(19).
-
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? Int J Mol Sci. 2020 Sep 15; 21(18).